JOHNSON & JOHNSON ACQUIRES SAVLON OTC BRANDS FROM ICI
JOHNSON & JOHNSON ACQUIRES SAVLON OTC BRANDS FROM ICI NEW BRUNSWICK, N.J., May 22 /PRNewswire/ -- Johnson & Johnson
See: New York Stock Exchange : JNJ JNJ Johnson and Johnson (stock symbol)
JNJ Journal of Nursing Jocularity ) today announced it has acquired the rights in more than 70 countries to the Savlon OTC OTC
See over-the-counter market (OTC). products line of London-based Imperial Chemical Industries (ADRs - NYSE: ICI (language) ICI - An extensible, interpretated language by Tim Long with syntax similar to C. ICI adds high-level garbage-collected associative data structures, exception handling, sets, regular expressions, and dynamic arrays. ). Terms of the sale were not disclosed.
The major brands in the line are Savlon liquid and Savlon cream antiseptic products used for first aid, diaper rash and skin disorders; and an antiseptic first aid spray. The agreement enables Johnson & Johnson to market the Savlon line in most countries outside the European Economic Community, including the Far East, Africa and Latin America. In addition to the Savlon trademark, the sale includes production equipment in Taiwan and South Africa. Johnson & Johnson believes the Savlon products are a valuable addition that will enhance the company's efforts to build and strengthen its over-the-counter business overseas, particularly in the Far East. Johnson & Johnson, with over 82,000 employees, is the world's largest and most comprehensive manufacturer of health care products serving the consumer, pharmaceutical and professional markets. -0- 5/22/92 /CONTACT: F. Robert Kniffin of Johnson & Johnson, 908-524-3535/ (JNJ ICI) CO: Johnson & Johnson; Imperial Chemical Industries ST: New Jersey IN: MTC SU: TNM
GK-OS -- NY007 -- 3205 05/22/92 10:01 EDT